Skip to content

Efficacy Evaluation of Unani Formulation in the Management of Baul Fil-Firash (Nocturnal Enuresis)

Efficacy Evaluation of Unani Formulation in the Management of Baul Fil-Firash (Nocturnal Enuresis) A Randomized single blind placebo-controlled Study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070601
Enrollment
60
Registered
2024-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

Intervention1: Unani formulation: Punica granulatum, Tamarix gallica, Coriandrum sativum, Accacia arabica, Boswellia serrata, Quercus incana: 3-5 gm of safoof (Powder) of Unani Formulation given orall

Sponsors

Saiyeda Zainab Fatima
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient who are fulfilling DSM-5 Criteria as mentioned below: 1. Involuntary or intentional, repeated voiding of urine into bed or clothes. 2. The behaviour should be clinically significant as manifested by either a frequency of twice a week for at least 3 consecutive months or the presence of clinically significant distress or impairment in social, academic (occupational), or other important areas of functioning. 3. Chronological age is at least 5-years. 4. The behaviour is not due exclusively to the direct physiological effect of a substance (e.g. a diuretic or an antipsychotic medication) or another medical condition(e.g.Diabetes, Spina bifida, a seizure disorder)

Exclusion criteria

Exclusion criteria: 1. Patient below 5 years 2. Patient above 14 years 3. Patient with anatomical malformation such as hypospadias 4. Mental Impairment 5. Urinary Tract Infection 6. Known case of diabetes insipidus 7. Diabetes mellitus type 1 and type 2 8. Patient guardian who fails to give consent 9. Patient who fails to follow up

Design outcomes

Primary

MeasureTime frame
Change in the frequency of involuntary voiding of urine during nightTimepoint: 45 days

Secondary

MeasureTime frame
Change in other symptoms like shamefulness, fear, Aggressiveness, IrritabilityTimepoint: 45 days

Countries

India

Contacts

Public ContactDr MD SOHAIL

State Unani Medical College

shlt869@gmail.com8279944096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026